Research | Departments
Research
Departments
Research | Departments
Research
Departments
Professor
Integrative research of clinical medical treatment on chronic kidney disease, benign prostatic hyperplasia, diabetes
Laboratory of Urological Disease
misspeng@tmu.edu.tw
Dr. Peng’ research include topics-related kidney disease, prostate cancer and bladder cancer.
1. Kuan-Chou Chen (Professor)
2. Trayee Dhar (Research assistant)
3. John Lee (Master student)
1. Peng CC, Chen CY, Chen CR, Chen CJ, Shen KH, ChenKC*, Peng RY. Renal Damaging Effect Elicited by Bicalutamide Therapy Uncovered Multiple Action Mechanisms As Evidenced by the Cell Model. Sci Rep. 2019 Mar 4;9(1):3392
2. Chen KC, Chen CR, Chen CY, Tzou KY, Peng CC*, Peng RY. Bicalutamide Elicits Renal Damage by Causing Mitochondrial Dysfunction via ROS Damage and Upregulation of HIF-1. Int J Mol Sci. 2020;21(9):E3400.
3. Peng CC, Chen CR, Chen CY, Lin YC, Chen KC, Peng RY. Nifedipine Upregulates ATF6-α, Caspases -12, -3, and -7 Implicating Lipotoxicity-Associated Renal ER Stress. Int J Mol Sci. 2020;21(9):E3147.
4. Chen KC, Chen CR, Chen CY, Peng CC*, Peng RY. Bicalutamide Exhibits Potential to Damage Kidney via Destroying Complex I and Affecting Mitochondrial Dynamics. J. Clin. Med. 2021, 12, 135.
5. Peng CC, Chen CR, Chen CY, Chen KC, Peng RY. Bicalutamide may enhance kidney injury in diabetes by concomitantly damaging energy production from OXPHOS and glycolysis. Chem Biol Interact. 2022 Apr 1;356:109858.